Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics), By Technique, By End-use, By Region, And Segment Forecasts, 2025 - 2033
Description
Lateral Flow Assays Market Summary
The global lateral flow assays market size was estimated at USD 9.85 billion in 2024 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 6.98% from 2025 to 2033. Factors including the growing incidence of infectious diseases, ongoing technological advances in assay design and manufacturing, and the increased implementation of rapid diagnostic tests in home care and point-of-care testing facilitate this trend.
Infectious diseases remain one of the main global health challenges; for example, the World Health Organization (WHO) reported 263 million estimated malaria cases around the world in 2023, highlighting the need for rapid, inexpensive, and accurate diagnostic products such as lateral flow tests. Technological advancements now allow for improved performance and use of lateral flow assays (LFAs), including advances in sensitivity, specificity, multiplexing, and digital applications via smartphone apps and cloud-connected devices. The latter advances have meant that lateral flow devices may be used in areas outside infectious disease detection, including pregnancy testing, heart disease monitoring, veterinary diagnostics, environmental testing, and food safety.
As part of the advances above, Abingdon Health plc (UK) has established itself as a key player in the lateral flow industry. In May 2024, Abingdon Health plc launched Boots' own-brand saliva-based pregnancy self-test in the United Kingdom and online via Salignostics and Crest Medical. This product represents a technological shift from traditional urine-based pregnancy tests to non-invasive saliva testing, thus providing greater convenience and accessibility for the user. In addition to launching the product, the significant advancement in product innovation provided an opportunity to further strengthen Abingdon Health's strategic partnership with Boots as the first company to adapt a saliva pregnancy self-test into Boots' own-brand range. These advances demonstrate how biotechnology innovation, consumer health, and strategic partnerships continue to influence the direction of the global LFAs market.
Global Lateral Flow Assays Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global lateral flow assays market report based on product, application, technique, end use, and region:
The global lateral flow assays market size was estimated at USD 9.85 billion in 2024 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 6.98% from 2025 to 2033. Factors including the growing incidence of infectious diseases, ongoing technological advances in assay design and manufacturing, and the increased implementation of rapid diagnostic tests in home care and point-of-care testing facilitate this trend.
Infectious diseases remain one of the main global health challenges; for example, the World Health Organization (WHO) reported 263 million estimated malaria cases around the world in 2023, highlighting the need for rapid, inexpensive, and accurate diagnostic products such as lateral flow tests. Technological advancements now allow for improved performance and use of lateral flow assays (LFAs), including advances in sensitivity, specificity, multiplexing, and digital applications via smartphone apps and cloud-connected devices. The latter advances have meant that lateral flow devices may be used in areas outside infectious disease detection, including pregnancy testing, heart disease monitoring, veterinary diagnostics, environmental testing, and food safety.
As part of the advances above, Abingdon Health plc (UK) has established itself as a key player in the lateral flow industry. In May 2024, Abingdon Health plc launched Boots' own-brand saliva-based pregnancy self-test in the United Kingdom and online via Salignostics and Crest Medical. This product represents a technological shift from traditional urine-based pregnancy tests to non-invasive saliva testing, thus providing greater convenience and accessibility for the user. In addition to launching the product, the significant advancement in product innovation provided an opportunity to further strengthen Abingdon Health's strategic partnership with Boots as the first company to adapt a saliva pregnancy self-test into Boots' own-brand range. These advances demonstrate how biotechnology innovation, consumer health, and strategic partnerships continue to influence the direction of the global LFAs market.
Global Lateral Flow Assays Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global lateral flow assays market report based on product, application, technique, end use, and region:
- Product Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
- Kits & Reagents
- Lateral Flow Readers
- Digital/Mobile Readers
- Benchtop Readers
- Application Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
- Clinical Testing
- Infectious Diseases Testing
- COVID-19 Testing
- Mosquito Borne Disease Testing
- Influenza Testing
- Sexually Transmitted Infection Testing
- HIV Testing
- HPV Testing
- Chlamydia Testing
- Gonorrhea Testing
- Syphilis Testing
- Others
- Hepatitis
- Tuberculosis
- Others
- Cardiac Marker Testing
- Troponin I and T Testing
- CK-MB Testing
- BNP and NT-proBNP Testing
- Myoglobin Testing
- D-Dimer Testing
- Others
- Pregnancy & Fertility Testing
- Pregnancy Testing
- Fertility Testing
- Cholesterol Testing/Lipid Profile Testing
- Drugs of Abuse Testing
- Others
- Veterinary Diagnostics
- Food safety & Environment Testing
- Drug Development & Quality Testing
- Technique Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
- End Use Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical & Biotechnology Companies
- Others
- Regional Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
176 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Lateral Flow Assay Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million, Volume, in thousands)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.1.1. Increasing prevalence of infectious diseases
- 3.3.1.2. Technological advancements in lateral flow
- 3.3.1.3. Growing adoption in homecare settings
- 3.3.2. Market Restraints Analysis
- 3.3.2.1. Stringent Regulations
- 3.3.3. Market Opportunities Analysis
- 3.3.3.1. Growing demand for Point-of-Care (POC) Testing
- 3.3.3.2. Expanding applications beyond healthcare
- 3.3.4. Market Challenges Analysis
- 3.3.4.1. Product Recalls
- 3.4. Lateral Flow Assay Market Analysis Tools
- 3.4.1. Porter’s Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.3. Pipeline
- 3.4.4. Case Study
- Chapter 4. Lateral Flow Assay Market: Product Estimates & Trend Analysis
- 4.1. Lateral Flow Assay Market: Product Movement Analysis
- 4.2. Lateral Flow Assay Market Estimates and Forecasts, by Product (USD Million, Volume in thousands), 2024 & 2033
- 4.3. Kits & Reagents
- 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 4.4. Lateral Flow Readers
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 4.4.2. Benchtop Readers
- 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 4.4.3. Digital Readers
- 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- Chapter 5. Lateral Flow Assay Market: Application Estimates & Trend Analysis
- 5.1. Lateral Flow Assay Market: Application Movement Analysis
- 5.2. Lateral Flow Assay Market Estimates and Forecasts, by Application (USD Million, Volume in thousands), 2024 & 2033
- 5.3. Clinical Testing
- 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2. Infectious Disease Testing
- 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.2. COVID-19
- 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.3. Mosquito Borne Disease Testing
- 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.4. Influenza Testing
- 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5. Sexually Transmitted Infection Testing
- 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.2. HIV Testing
- 5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.3. HPV Testing
- 5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.4. Chlamydia Testing
- 5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.5. Gonorrhea Testing
- 5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.6. Syphilis Testing
- 5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.5.7. Other STI Testing
- 5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.6. Hepatitis
- 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.7. Tuberculosis
- 5.3.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.2.8. Other Infectious Diseases
- 5.3.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3. Cardiac Marker Testing
- 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.2. Troponin I and T Testing
- 5.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.3. CK-MB Testing
- 5.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.4. BNP and NT-Probnp Testing
- 5.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.5. Myoglobin Testing
- 5.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.6. D-Dimer Testing
- 5.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.3.7. Other Cardiac Marker Tests
- 5.3.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.4. Pregnancy & Fertility Testing
- 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.4.2. Pregnancy Testing
- 5.3.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.4.3. Fertility Testing
- 5.3.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.5. Cholesterol Testing/Lipid Profile
- 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.6. Drugs of Abuse Testing
- 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.3.7. Other Clinical Tests
- 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.4. Veterinary Diagnostics
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.5. Food Safety & Environment Testing
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 5.6. Drug Development & Quality Testing
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- Chapter 6. Lateral Flow Assay Market: Technique Estimates & Trend Analysis
- 6.1. Lateral Flow Assay Market: Technique Movement Analysis
- 6.2. Lateral Flow Assay Market Estimates and Forecasts, by Technique (USD Million, Volume in thousands), 2024 & 2033
- 6.3. Sandwich Assays
- 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 6.4. Competitive Assays
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 6.5. Multiplex Detection Assays
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- Chapter 7. Lateral Flow Assay Market: End Use Estimates & Trend Analysis
- 7.1. Lateral Flow Assay Market: End Use Movement Analysis
- 7.2. Lateral Flow Assay Market Estimates and Forecasts, by End Use (USD Million, Volume in thousands), 2024 & 2033
- 7.3. Hospitals & Clinics
- 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 7.4. Diagnostic Laboratories
- 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 7.5. Home Care
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 7.6. Pharmaceutical & Biotechnology Companies
- 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 7.7. Other End Use
- 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- Chapter 8. Lateral Flow Assay Market: Regional Estimates & Trend Analysis
- 8.1. Lateral Flow Assay Market Share, By Region, 2024 & 2033, USD Million
- 8.2. North America
- 8.2.1. North America Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. Reimbursement Scenario
- 8.2.2.5. U.S. Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Reimbursement Scenario
- 8.2.3.5. Canada Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Reimbursement Scenario
- 8.2.4.5. Mexico Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3. Europe
- 8.3.1. Europe Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. Reimbursement Scenario
- 8.3.2.5. UK Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Reimbursement Scenario
- 8.3.3.5. Germany Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Reimbursement Scenario
- 8.3.4.5. France Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Reimbursement Scenario
- 8.3.5.5. Italy Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Reimbursement Scenario
- 8.3.6.5. Spain Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Reimbursement Scenario
- 8.3.7.5. Denmark Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Reimbursement Scenario
- 8.3.8.5. Sweden Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Reimbursement Scenario
- 8.3.9.5. Norway Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Reimbursement Scenario
- 8.4.2.5. Japan Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Reimbursement Scenario
- 8.4.3.5. China Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Reimbursement Scenario
- 8.4.4.5. India Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Reimbursement Scenario
- 8.4.5.5. Australia Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.6. South Korea
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Reimbursement Scenario
- 8.4.6.5. South Korea Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.4.7. Thailand
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Reimbursement Scenario
- 8.4.7.5. Thailand Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.5. Latin America
- 8.5.1. Latin America Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement Scenario
- 8.5.2.5. Brazil Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement Scenario
- 8.5.3.5. Argentina Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement Scenario
- 8.6.2.5. South Africa Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement Scenario
- 8.6.3.5. Saudi Arabia Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement Scenario
- 8.6.4.5. UAE Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement Scenario
- 8.6.5.5. Kuwait Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Heat Map Analysis
- 9.4. Company Profiles
- 9.4.1. Abbott
- 9.4.1.1. Participant’s Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Bio-Rad Laboratories, Inc
- 9.4.2.1. Participant’s Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Siemens Healthineers AG
- 9.4.3.1. Participant’s Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. BIOMÉRIEUX
- 9.4.4.1. Participant’s Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. BD
- 9.4.5.1. Participant’s Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. QIAGEN
- 9.4.6.1. Participant’s Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. QuidelOrtho Corporation
- 9.4.7.1. Participant’s Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. F. Hoffmann-La Roche
- 9.4.8.1. Participant’s Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. DH Life Sciences, LLC.
- 9.4.9.1. Participant’s Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Quest Diagnostics
- 9.4.10.1. Participant’s Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Recent Developments/ Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
